@article{10523,
  author = {E. Rivero-Ferrer and M. Olesen and E. Plana and J. Aguado and N. Saigi-Morgui and A. Rubino and S. Daoud and A. Lei and S. Perez-Gutthann and T. Schink and N. Kristiansen and J. Hallas and A. Pottegard and C. Rebordosa},
  title = {Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany},
  year = {2022},
  journal = {Clin Drug Investig},
  edition = {2022/03/16},
  isbn = {1173-2563},
  doi = {10.1007/s40261-022-01120-2},
  note = {1179-1918
Rivero-Ferrer, Elena
Orcid: 0000-0001-5093-2445
Olesen, Morten
Orcid: 0000-0002-0937-4952
Plana, Estel
Orcid: 0000-0001-8675-7503
Aguado, Jaume
Orcid: 0000-0002-9575-0212
Saigí-Morgui, Núria
Orcid: 0000-0003-2503-1818
Rubino, Annalisa
Daoud, Sami Z
Lei, Alejhandra
Perez-Gutthann, Susana
Orcid: 0000-0001-5798-3691
Schink, Tania
Orcid: 0000-0003-2252-1475
Kristiansen, Nina Sahlertz
Orcid: 0000-0002-8097-8708
Hallas, Jesper
Orcid: 0000-0001-9314-5679
Pottegård, Anton
Orcid: 0000-0002-8064-5997
Rebordosa, Cristina
Orcid: 0000-0002-0224-1866
Journal Article
New Zealand
Clin Drug Investig. 2022 Mar 15. doi: 10.1007/s40261-022-01120-2.},
  language = {eng},
}